Byelyankacin: A novel melanogenesis inhibitor produced by Enterobacter sp. B20

  • Senji Takahashi
  • , Hiroki Iwai
  • , Kunio Kosaka
  • , Toshitsugu Miyazaki
  • , Yuko Osanai
  • , Nakako Arao
  • , Kouichi Tanaka
  • , Koji Nagai
  • , Akira Nakagawa

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Abstract

A novel melanogenesis inhibitor, byelyankacin (1), was isolated from the fermentation broth of a bacterial strain. The producing organism, designated B20, was identified as a member of the genus Enterobacter based on taxonomic characteristics. 1 was obtained as a white powder from the culture medium by solvent extraction and serial chromatographic purification. The structure of 1 was determined as (E)-4-(2-isocyanovinyl)phenyl α-L-rhamnopyranoside on the basis of spectroscopic data. 1 potently inhibited mushroom tyrosinase and melanogenesis of B16-2D2 melanoma cells with IC50 value of 2.1 nM and 30 nM, respectively.

Original languageEnglish
Pages (from-to)717-720
Number of pages4
JournalJournal of Antibiotics
Volume60
Issue number11
DOIs
StatePublished - Nov 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • B16-2D2 melanoma cell
  • Byelyankacin
  • Enterobacter sp.
  • Melanogenesis inhibitor
  • Mushroom tyrosinase

Fingerprint

Dive into the research topics of 'Byelyankacin: A novel melanogenesis inhibitor produced by Enterobacter sp. B20'. Together they form a unique fingerprint.

Cite this